Ati Physical Therapy, INC
Market Movers (8-K)
ATI Physical Therapy finalized a $26 million convertible note financing to bolster its financial position.
Worse than expected
Capital raise
ATI Physical Therapy, Inc. announces the appointment of Scott Rundell as Interim Chief Financial Officer, effective January 13, 2025, following the resignation of Joseph Jordan.
Worse than expected
ATI Physical Therapy reaffirmed its fourth-quarter 2024 financial guidance, previously provided in November 2024, while navigating delisting from the NYSE and ongoing financial challenges.
Worse than expected
Capital raise
ATI Physical Therapy's Chief Financial Officer, Joseph Jordan, has announced his resignation, effective January 10, 2025, to pursue other opportunities.
ATI Physical Therapy has amended its credit agreement and note purchase agreement, allowing for the issuance of new debt and a tender offer for its common stock.
Worse than expected
Capital raise
ATI Physical Therapy's Class A common stock will be delisted from the New York Stock Exchange due to non-compliance with listing rules and will transition to the OTC Pink Market.
Worse than expected
Capital raise
Quarterly Earnings (10-Q)
ATI Physical Therapy's Q3 2024 results show increased revenue driven by higher patient volumes, but the company continues to face liquidity challenges and substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
ATI Physical Therapy saw revenue growth and reduced net losses in the second quarter of 2024, but substantial doubt remains about its ability to continue as a going concern.
Worse than expected
Capital raise
ATI Physical Therapy's first quarter 2024 results show improvements in patient visits and revenue per visit, but the company continues to face financial challenges and going concern doubts.
Worse than expected
Capital raise
Annual Reports (10-K)
ATI Physical Therapy's latest 10-K filing highlights continued financial challenges, including substantial doubt about its ability to continue as a going concern, alongside strategic efforts to improve operations and explore alternative liquidity options.
Capital raise
Worse than expected
10-K: ATI Physical Therapy Details Securities in 10-K Filing, Outlines Share Structure and Warrant Terms
ATI Physical Therapy's 10-K filing provides a detailed overview of its registered securities, including common stock, warrants, and preferred stock, along with key dates and terms.
Capital raise
Insider Trading (Form 4)
CEO Sharon Vitti disposed of 1,611 shares of ATI Physical Therapy to cover tax obligations upon vesting of Restricted Stock Units.
Interim CFO Scott Rundell reports disposition of shares to cover tax obligations upon vesting of Restricted Stock Units.
CEO Sharon Vitti disposed of 10,026 shares of ATI Physical Therapy, Inc. to cover tax withholding obligations upon vesting of Restricted Stock Units.
Eimile Tansey, Chief People Officer of ATI Physical Therapy, reports the withholding of shares to cover tax obligations upon vesting of Restricted Stock Units.
Augustus Oakes, Chief Information Officer of ATI Physical Therapy, Inc., reports the disposal of 1,697 shares of Class A Common Stock to cover tax obligations upon vesting of restricted stock units.
Erik Kantz, Chief Legal Officer of ATI Physical Therapy, reports the disposal of 1,697 shares of Class A Common Stock to cover tax obligations upon vesting of restricted stock units and awards.
Proxy Statements (Def-14A)
ATI Physical Therapy, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on June 12, 2024, outlining proposals for ratification, director elections, executive compensation, and an equity incentive plan amendment.
ATI Physical Therapy will hold its 2024 Annual Meeting of Stockholders virtually on June 12, 2024, to vote on key proposals including director elections, auditor ratification, executive compensation, and an amendment to the equity incentive plan.